SCN5A and cardiac rhythm disease: However, our data from human hiPSC-CMs and transgenic cell line (Nav1.5-HEK293), controlled by Guinea-pig ventricular myocytes, minimized the possibility that ACO-increased cytosolic [Na+]i in human cardiomyocytes acts as the main driver of cardiac arrhythmia [13,14].